9 results on '"Nicoletti, Carmine"'
Search Results
2. Proliferation of Multiple Cell Types in the Skeletal Muscle Tissue Elicited by Acute p21 Suppression.
- Author
-
Biferi, Maria Grazia, Nicoletti, Carmine, Falcone, Germana, Puggioni, Eleonora M R, Passaro, Nunzia, Mazzola, Alessia, Pajalunga, Deborah, Zaccagnini, Germana, Rizzuto, Emanuele, Auricchio, Alberto, Zentilin, Lorena, De Luca, Gabriele, Giacca, Mauro, Martelli, Fabio, Musio, Antonio, Musarò, Antonio, and Crescenzi, Marco
- Subjects
- *
STRIATED muscle , *SKELETAL muscle , *MEDICINE , *DNA , *ADENO-associated virus - Abstract
Although in the last decades the molecular underpinnings of the cell cycle have been unraveled, the acquired knowledge has been rarely translated into practical applications. Here, we investigate the feasibility and safety of triggering proliferation in vivo by temporary suppression of the cyclin-dependent kinase inhibitor, p21. Adeno-associated virus (AAV)-mediated, acute knockdown of p21 in intact skeletal muscles elicited proliferation of multiple, otherwise quiescent cell types, notably including satellite cells. Compared with controls, p21-suppressed muscles exhibited a striking two- to threefold expansion in cellularity and increased fiber numbers by 10 days post-transduction, with no detectable inflammation. These changes partially persisted for at least 60 days, indicating that the muscles had undergone lasting modifications. Furthermore, morphological hyperplasia was accompanied by 20% increases in maximum strength and resistance to fatigue. To assess the safety of transiently suppressing p21, cells subjected to p21 knockdown in vitro were analyzed for γ-H2AX accumulation, DNA fragmentation, cytogenetic abnormalities, ploidy, and mutations. Moreover, the differentiation competence of p21-suppressed myoblasts was investigated. These assays confirmed that transient suppression of p21 causes no genetic damage and does not impair differentiation. Our results establish the basis for further exploring the manipulation of the cell cycle as a strategy in regenerative medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway.
- Author
-
Cacchiarelli, Davide, Martone, Julie, Girardi, Erika, Cesana, Marcella, Incitti, Tania, Morlando, Mariangela, Nicoletti, Carmine, Santini, Tiziana, Sthandier, Olga, Barberi, Laura, Auricchio, Alberto, Musarò, Antonio, and Bozzoni, Irene
- Subjects
NON-coding RNA ,DUCHENNE muscular dystrophy ,DYSTROPHIN ,NITRIC-oxide synthases ,SARCOLEMMA ,EXTRACELLULAR matrix proteins ,MUSCLE regeneration ,GENE expression - Abstract
Summary: In Duchenne muscular dystrophy (DMD) the absence of dystrophin at the sarcolemma delocalizes and downregulates nitric oxide synthase (nNOS); this alters S-nitrosylation of HDAC2 and its chromatin association. We show that the differential HDAC2 nitrosylation state in Duchenne versus wild-type conditions deregulates the expression of a specific subset of microRNA genes. Several circuitries controlled by the identified microRNAs, such as the one linking miR-1 to the G6PD enzyme and the redox state of cell, or miR-29 to extracellular proteins and the fibrotic process, explain some of the DMD pathogenetic traits. We also show that, at variance with other myomiRs, miR-206 escapes from the dystrophin-nNOS control being produced in activated satellite cells before dystrophin expression; in these cells, it contributes to muscle regeneration through repression of the satellite specific factor, Pax7. We conclude that the pathway activated by dystrophin/nNOS controls several important circuitries increasing the robustness of the muscle differentiation program. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
4. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity.
- Author
-
Dobrowolny, Gabriella, Aucello, Michela, Rizzuto, Emanuele, Beccafico, Sara, Mammucari, Cristina, Bonconpagni, Simona, Belia, Silvia, Wannenes, Francesca, Nicoletti, Carmine, Del Prete, Zaccaria, Rosenthal, Nadia, Molinaro, Mario, Protasi, Feliciano, Fanò, Giorgio, Sandri, Marco, and Musarò, Antonio
- Subjects
SUPEROXIDE dismutase ,ANTIOXIDANTS ,HOMEOSTASIS ,LABORATORY mice ,OXIDATIVE stress ,MUSCULAR atrophy ,GENE expression ,MUSCLE strength - Abstract
Summary: The antioxidant enzyme superoxide dismutase 1 (SOD1) is a critical player of the antioxidative defense whose activity is altered in several chronic diseases, including amyotrophic lateral sclerosis. However, how oxidative insult affects muscle homeostasis remains unclear. This study addresses the role of oxidative stress on muscle homeostasis and function by the generation of a transgenic mouse model expressing a mutant SOD1 gene (SOD1
G93A ) selectively in skeletal muscle. Transgenic mice developed progressive muscle atrophy, associated with a significant reduction in muscle strength, alterations in the contractile apparatus, and mitochondrial dysfunction. The analysis of molecular pathways associated with muscle atrophy revealed that accumulation of oxidative stress served as signaling molecules to initiate autophagy, one of the major intracellular degradation mechanisms. These data demonstrate that skeletal muscle is a primary target of SOD1G93A -mediated toxicity and disclose the molecular mechanism whereby oxidative stress triggers muscle atrophy. [Copyright &y& Elsevier]- Published
- 2008
- Full Text
- View/download PDF
5. Phenformin Inhibits Hedgehog-Dependent Tumor Growth through a Complex I-Independent Redox/Corepressor Module.
- Author
-
Di Magno, Laura, Manni, Simona, Di Pastena, Fiorella, Coni, Sonia, Macone, Alberto, Cairoli, Sara, Sambucci, Manolo, Infante, Paola, Moretti, Marta, Petroni, Marialaura, Nicoletti, Carmine, Capalbo, Carlo, De Smaele, Enrico, Di Marcotullio, Lucia, Giannini, Giuseppe, Battistini, Luca, Goffredo, Bianca Maria, Iorio, Egidio, Agostinelli, Enzo, and Maroder, Marella
- Abstract
The antidiabetic drug phenformin displays potent anticancer activity in different tumors, but its mechanism of action remains elusive. Using Shh medulloblastoma as model, we show here that at clinically relevant concentrations, phenformin elicits a significant therapeutic effect through a redox-dependent but complex I-independent mechanism. Phenformin inhibits mitochondrial glycerophosphate dehydrogenase (mGPD), a component of the glycerophosphate shuttle, and causes elevations of intracellular NADH content. Inhibition of mGPD mimics phenformin action and promotes an association between corepressor CtBP2 and Gli1, thereby inhibiting Hh transcriptional output and tumor growth. Because ablation of CtBP2 abrogates the therapeutic effect of phenformin in mice, these data illustrate a biguanide-mediated redox/corepressor interplay, which may represent a relevant target for tumor therapy. • Therapeutic doses of phenformin suppress Hedgehog-dependent tumor growth • Phenformin inhibits mGPD in cancer cells but does not affect complex I activity • Inhibition of tumor mGPD mimics phenformin and increases redox state/NADH content • Elevated NADH promotes Gli1/CtBP2 complex formation and inhibition of tumor growth Di Magno et al. investigate the therapeutic properties of phenformin in Hedgehog-dependent tumors. At clinically relevant doses, phenformin works independent of respiratory complex I through mGPD-mediated increase of the redox state. This promotes CtBP2/Gli1 complex formation and consequent inhibition of Hedgehog transcriptional output and tumor growth. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity.
- Author
-
Dobrowolny, Gabriella, Aucello, Michela, Rizzuto, Emanuele, Beccafico, Sara, Mammucari, Cristina, Boncompagni, Simona, Belia, Silvia, Wannenes, Francesca, Nicoletti, Carmine, Del Prete, Zaccaria, Rosenthal, Nadia, Molinaro, Mario, Protasi, Feliciano, Fanò, Giorgio, Sandri, Marco, and Musarò, Antonio
- Published
- 2009
- Full Text
- View/download PDF
7. Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.
- Author
-
Infante, Paola, Malfanti, Alessio, Quaglio, Deborah, Balducci, Silvia, De Martin, Sara, Bufalieri, Francesca, Mastrotto, Francesca, Basili, Irene, Garofalo, Mariangela, Lospinoso Severini, Ludovica, Mori, Mattia, Manni, Isabella, Moretti, Marta, Nicoletti, Carmine, Piaggio, Giulia, Caliceti, Paolo, Botta, Bruno, Ghirga, Francesca, Salmaso, Stefano, and Di Marcotullio, Lucia
- Subjects
- *
TUMOR growth , *ANIMAL models in research , *MICELLES , *MEDULLOBLASTOMA , *DRUG stability , *CEREBELLAR tumors , *PROTEIN metabolism , *PROTEINS , *DRUG delivery systems , *BIOLOGICAL models , *RESEARCH , *CELL culture , *COLLOIDS , *BLOOD-brain barrier , *CLINICAL drug trials , *STEROIDS , *ANIMAL experimentation , *RESEARCH methodology , *GLIOMAS , *ANTINEOPLASTIC agents , *MEDICAL cooperation , *EVALUATION research , *BRAIN tumors , *CELLULAR signal transduction , *COMPARATIVE studies , *POLYETHYLENE glycol , *CHROMONES , *CELL lines , *MICE , *DOSAGE forms of drugs , *CHEMICAL inhibitors - Abstract
Aberrant activation of the Hedgehog (Hh) pathway leads to the development of several tumors, including medulloblastoma (MB), the most common pediatric brain malignancy. Hh inhibitors acting on GLI1, the final effector of Hh signaling, offer a valuable opportunity to overcome the pitfalls of the existing therapies to treat Hh-driven cancers. In this study, the toxicity, delivery, biodistribution, and anticancer efficacy of Glabrescione B (GlaB), a selective GLI1 inhibitor, were investigated in preclinical models of Hh-dependent MB. To overcome its poor water solubility, GlaB was formulated with a self-assembling amphiphilic polymer forming micelles, called mPEG5kDa-cholane. mPEG5kDa-cholane/GlaB showed high drug loading and stability, low cytotoxicity, and long permanence in the bloodstream. We found that mPEG5kDa-cholane efficiently enhanced the solubility of GlaB, thus avoiding the use of organic solvents. mPEG5kDa-cholane/GlaB possesses favorable pharmacokinetics and negligible toxicity. Remarkably, GlaB encapsulated in mPEG5kDa-cholane micelles was delivered through the blood-brain barrier and drastically inhibited tumor growth in both allograft and orthotopic models of Hh-dependent MB. Our findings reveal that mPEG5kDa-cholane/GlaB is a good candidate for the treatment of Hh-driven tumors and provide relevant implications for the translation of GlaB into clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice.
- Author
-
Chiappalupi, Sara, Luca, Giovanni, Mancuso, Francesca, Madaro, Luca, Fallarino, Francesca, Nicoletti, Carmine, Calvitti, Mario, Arato, Iva, Falabella, Giulia, Salvadori, Laura, Di Meo, Antonio, Bufalari, Antonello, Giovagnoli, Stefano, Calafiore, Riccardo, Donato, Rosario, and Sorci, Guglielmo
- Subjects
- *
TREATMENT of Duchenne muscular dystrophy , *MICROENCAPSULATION , *INTRAPERITONEAL injections , *IMMUNOSUPPRESSIVE agents , *DRUG delivery systems - Abstract
Duchenne muscular dystrophy (DMD) is a genetic disease characterized by progressive muscle degeneration leading to impaired locomotion, respiratory failure and premature death. In DMD patients, inflammatory events secondary to dystrophin mutation play a major role in the progression of the pathology. Sertoli cells (SeC) have been largely used to protect xenogeneic engraftments or induce trophic effects thanks to their ability to secrete trophic, antiinflammatory, and immunomodulatory factors. Here we have purified SeC from specific pathogen-free (SPF)-certified neonatal pigs, and embedded them into clinical grade alginate microcapsules. We show that a single intraperitoneal injection of microencapsulated SPF SeC (SeC-MC) in an experimental model of DMD can rescue muscle morphology and performance in the absence of pharmacologic immunosuppressive treatments. Once i.p. injected, SeC-MC act as a drug delivery system that modulates the inflammatory response in muscle tissue, and upregulates the expression of the dystrophin paralogue, utrophin in muscles through systemic release of heregulin-β1, thus promoting sarcolemma stability. Analyses performed five months after single injection show high biocompatibility and long-term efficacy of SeC-MC. Our results might open new avenues for the treatment of patients with DMD and related diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
9. p66ShcA and Oxidative Stress Modulate Myogenic Differentiation and Skeletal Muscle Regeneration after Hind Limb lschemia.
- Author
-
Zaccagnini, Germana, Martelli, Fabio, Magenta, Alessandra, Cencioni, Chiara, Fasanaro, Pasquale, Nicoletti, Carmine, Biglioli, Paolo, Pelicci, Pier Giuseppe, and Capogrossi, Maurizio C.
- Subjects
- *
OXIDATIVE stress , *OXIDATION-reduction reaction , *MYOBLASTS , *CELL differentiation , *MUSCLE regeneration , *ISCHEMIA , *BIOCHEMISTRY - Abstract
Oxidative stress plays a pivotal role in ischemic injury, and p66ShcAko mice exhibit both lower oxidative stress and decreased tissue damage following hind limb ischemia. Thus, it was investigated whether tissue regeneration following acute hind limb ischemia was altered in p66ShcAko mice. Upon femoral artery dissection, muscle regeneration started earlier and was completed faster than in wild-type (WT) control. Moreover, faster regeneration was associated with decreased oxidative stress. Unlike ischemia, cardiotoxin injury induced similar skeletal muscle damage in both genotypes. However, p66ShcAko mice regenerated faster, in agreement with the regenerative advantage upon ischemia. Since no difference between p66ShcAwt and knock-out (ko) mice was found in blood perfusion recovery after ischemia, satellite cells (SCs), a resident population of myogenic progenitors, were examined. Similar SCs numbers were present in WT and ko mice. However, in vitro cultured p66ShcAko SCs displayed lower oxidative stress levels and higher proliferation rate and differentiated faster than WT, Furthermore, when exposed to sublethal H2O2 doses, p6ShcAko SCs were resistant to H2O2- induced inhibition of differentiation. Finally, myogenic conversion induced by MyoD overexpression was more efficient in p66ShcAko fibroblasts compared with WI. The present work demonstrates that oxidative stress and p66ShcA play a crucial role in the regenerative pathways activated by acute ischemia. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.